These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28117752)

  • 1. Therapeutic Potential of Induced Neural Stem Cells for Parkinson's Disease.
    Choi DH; Kim JH; Kim SM; Kang K; Han DW; Lee J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lmx1a enhances the effect of iNSCs in a PD model.
    Wu J; Sheng C; Liu Z; Jia W; Wang B; Li M; Fu L; Ren Z; An J; Sang L; Song G; Wu Y; Xu Y; Wang S; Chen Z; Zhou Q; Zhang YA
    Stem Cell Res; 2015 Jan; 14(1):1-9. PubMed ID: 25460246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of human induced neural stem cell-derived dopaminergic neurons by DREADD reveals therapeutic effects on a mouse model of Parkinson's disease.
    Wang X; Han D; Zheng T; Ma J; Chen Z
    Stem Cell Res Ther; 2024 Sep; 15(1):297. PubMed ID: 39256801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
    Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
    Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
    Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model.
    Yuan Y; Tang X; Bai YF; Wang S; An J; Wu Y; Xu ZD; Zhang YA; Chen Z
    Theranostics; 2018; 8(17):4679-4694. PubMed ID: 30279731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural stem cells transplanted in a mouse model of Parkinson's disease differentiate to neuronal phenotypes and reduce rotational deficit.
    Ziavra D; Makri G; Giompres P; Taraviras S; Thomaidou D; Matsas R; Mitsacos A; Kouvelas ED
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):829-35. PubMed ID: 23131156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural stem cells transplantation combined with ethyl stearate improve PD rats motor behavior by promoting NSCs migration and differentiation.
    Huang J; Yi L; Yang X; Zheng Q; Zhong J; Ye S; Li X; Li H; Chen D; Li C
    CNS Neurosci Ther; 2023 Jun; 29(6):1571-1584. PubMed ID: 36924304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engrafted primary type-2 astrocytes improve the recovery of the nigrostriatal pathway in a rat model of Parkinson's disease.
    Sun Y; Lu XJ; Fu X; Zhang Y; Zhan Y; Liu J; Zhao L; Xia CL
    Mol Cell Biochem; 2021 Feb; 476(2):619-631. PubMed ID: 33070275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic/xenogeneic transplantation of peptide-labeled mitochondria in Parkinson's disease: restoration of mitochondria functions and attenuation of 6-hydroxydopamine-induced neurotoxicity.
    Chang JC; Wu SL; Liu KH; Chen YH; Chuang CS; Cheng FC; Su HL; Wei YH; Kuo SJ; Liu CS
    Transl Res; 2016 Apr; 170():40-56.e3. PubMed ID: 26730494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural Stem Cell Grafts Promote Astroglia-Driven Neurorestoration in the Aged Parkinsonian Brain via Wnt/β-Catenin Signaling.
    L'Episcopo F; Tirolo C; Peruzzotti-Jametti L; Serapide MF; Testa N; Caniglia S; Balzarotti B; Pluchino S; Marchetti B
    Stem Cells; 2018 Aug; 36(8):1179-1197. PubMed ID: 29575325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation between dopaminergic response and motor behavior following intrastriatal, but not intravenous, transplant of bone marrow mononuclear stem cells in a mouse model of Parkinson's disease.
    Calice da Silva C; Azevedo BN; Machado DC; Zimmer ER; Martins LAM; da Costa JC
    Behav Brain Res; 2017 May; 324():30-40. PubMed ID: 28167338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined MSC-Secreted Factors and Neural Stem Cell Transplantation Promote Functional Recovery of PD Rats.
    Yao Y; Huang C; Gu P; Wen T
    Cell Transplant; 2016; 25(6):1101-13. PubMed ID: 26607204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engraftable Induced Pluripotent Stem Cell-Derived Neural Precursors for Brain Repair.
    Zygogianni O; Kouroupi G; Taoufik E; Matsas R
    Methods Mol Biol; 2020; 2155():23-39. PubMed ID: 32474865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 6-hydroxydopamine Rat Model of Parkinson's Disease.
    Guimarães RP; Ribeiro DL; Dos Santos KB; Godoy LD; Corrêa MR; Padovan-Neto FE
    J Vis Exp; 2021 Oct; (176):. PubMed ID: 34779439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM; Faull RL; Connor B
    Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-transplantation of GDNF-overexpressing neural stem cells and fetal dopaminergic neurons mitigates motor symptoms in a rat model of Parkinson's disease.
    Deng X; Liang Y; Lu H; Yang Z; Liu R; Wang J; Song X; Long J; Li Y; Lei D; Feng Z
    PLoS One; 2013; 8(12):e80880. PubMed ID: 24312503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
    Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.